Model prediction of treatment planning for dose-fractionated radioimmunotherapy.
- 12 February 2002
- Vol. 94 (4) , 1264-1269
- https://doi.org/10.1002/cncr.10295
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Red marrow dosimetry for radiolabeled antibodies that bind to marrow, bone, or blood componentsMedical Physics, 2000
- Defining the optimal spacing between repeat radioantibody doses in experimental modelsCancer, 1997
- What Tpot is notInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Overview of radiation myelotoxicity secondary to radioimmunotherapy using131 i-lym-1 as a modelCancer, 1994
- The Impact of Tumor Cell Proliferation in RadioimmunotherapyCancer, 1994
- Mathematical models of marrow cell kinetics: Differential effects of protracted irradiations on stromal and stem cells in miceInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Radiobiological aspects of low dose rates in radioimmunotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1990
- The linear-quadratic formula and progress in fractionated radiotherapyThe British Journal of Radiology, 1989
- The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapyThe British Journal of Radiology, 1985
- ORIGIN, PRODUCTION, AND LIFE-SPAN OF BLOOD PLATELETS**Supported in part by grant AM-08263 and Research Career Development Award 1-K3 AM-8634 from the National Institute of Arthritis and Metabolic Diseases, by a Research Grant from the American Cancer Society (Massachusetts Division), Inc., and Grant No. T-505 from the American Cancer Society, Inc.Published by Elsevier ,1971